Why Biophytis Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Several stocks are experiencing significant pre-market trading movements. Biophytis S.A. (BPTS) shares rose 31.5% following a partnership agreement with Skyepharma for the production of Sarconeos (BIO101). Avalo Therapeutics, Inc. (AVTX) shares gained 24% after the recent sale of its assets. Vapotherm, Inc. (VAPO) shares jumped 9.8% after announcing a clinical trial presentation. ESS Tech, Inc. (GWH) shares climbed 7.2% after Honeywell (HON) reported a strategic collaboration with the company. On the other hand, Rite Aid Corporation (RAD) shares fell 13.7% amid reports of potential bankruptcy.
September 25, 2023 | 12:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rite Aid shares fell 13.7% amid reports of potential bankruptcy.
Reports of potential bankruptcy are a major negative development for Rite Aid, likely leading to decreased investor confidence and a drop in share price.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Avalo Therapeutics shares gained 24% after the recent sale of its assets.
The sale of assets is generally seen as a positive move by investors, as it can free up capital for other investments or reduce debt. This likely led to the increase in Avalo's share price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Biophytis shares rose 31.5% following a partnership agreement with Skyepharma.
The partnership agreement with Skyepharma for the production of Sarconeos (BIO101) is a positive development for Biophytis, likely leading to increased investor confidence and a rise in share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
ESS Tech shares climbed 7.2% after Honeywell reported a strategic collaboration with the company.
The strategic collaboration with Honeywell is a positive development for ESS Tech, as it could lead to advancements in technology and market adoption. This likely led to increased investor confidence and a rise in share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Vapotherm shares jumped 9.8% after announcing a clinical trial presentation.
The announcement of a clinical trial presentation is a positive development for Vapotherm, as it suggests progress in their research and development efforts. This likely led to increased investor confidence and a rise in share price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100